Press Release

-1

archive,category,category-press-release,category-96,bridge-core-2.0.9,ajax_fade,page_not_loaded,,qode-theme-ver-19.6,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.1,vc_responsive

Press Release

Posted at 09 Jan, 14:27h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Receives Approval to Commence Phase 3 Trial in Finland

Posted at 17 Oct, 14:34h in Press Release by adialpharma 0 Comments

0 Likes

ADIAL PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FROM US PATENT AND TRADEMARK OFFICE FOR PATENT FOR THE TREATMENT OF ALCOHOL USE DISORDER IN PATIENTS IDENTIFIED USING A MOLECULAR GENETIC BIOMARKER

Posted at 25 Sep, 14:27h in Press Release by adialpharma 0 Comments

0 Likes

Adial Provides Update on Clinical Activities; Filing to Commence Phase 3 Trial on Track for Q3 2019

Posted at 11 Sep, 13:41h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Successful Product Retesting of AD04 for Phase 3 Clinical Trial

Posted at 09 May, 17:34h in Press Release by adialpharma 0 Comments

1 Like

Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder

Posted at 29 Apr, 19:39h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceutical’s Chief Medical Officer Dr. Bankole Johnson Featured on NBC West Palm Beach, Florida Affiliate

Posted at 26 Mar, 13:22h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer

Posted at 28 Feb, 15:13h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Featured on CBS in San Francisco

Posted at 20 Feb, 14:08h in Press Release by adialpharma 0 Comments

0 Likes

ADIAL PHARMACEUTICALS ANNOUNCES PARTNERSHIP WITH CATALENT TO PACKAGE AND DISTRIBUTE ADIAL’S AD04 FOR ITS PHASE 3 TRIAL

Posted at 12 Feb, 14:39h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder